Dr. Hughes Kramer's research focuses on respiratory viruses and vaccine effectiveness in immunocompromised adults. In addition to her own research, Dr. Hughes Kramer oversees the Translational Research Unit (TRU) Clinical Research.
Dr. Hughes Kramer is the Director of the Infectious Diseases Expanded Access (IDEA) center. In this role, she oversees all compassionate use, emergency investigational new drug (eIND), and single patient investigational new drug (SPIND) applications for the Division of Infectious Diseases. The IDEA Center has allowed physicians to access medications and biologics such as clofazimine, fosmanogepix, olorofim, SARS-CoV-2 T cells, and bacteriophages.
Dr. Hughes Kramer mentors public health graduate students interested in clinical infectious disease research through summer internships, masters essay committees, and the TRU student research assistant program. She gives lectures on infectious disease epidemiology and vaccine efficacy and effectiveness. Additionally, she is an adjunct professor at Duquesne University where she teaches the Introduction to Epidemiology course to undergraduates.
- BA, Biology, University of Delaware, 2014
- MPH, Epidemiology, University of Pittsburgh School of Public Health, 2017
- PhD, Epidemiology, University of Pittsburgh School of Public Health, 2023
Education & Training
Hughes, K., Middleton, D.B., Nowalk, M.P., et al. Effectiveness of Influenza Vaccine for Preventing Laboratory-Confirmed Influenza Hospitalizations in Immunocompromised Adults. Clinical Infectious Diseases. 2021; 73(11): e4353-e4360.
Haidar, G., Jacobs, J. L., Hughes Kramer, K., et al. Therapy with Allogeneic SARS-CoV-2-specific Tcells for Persistent COVID-19 in Immunocompromised Patients. Clinical Infectious Diseases. 2023; Epub Apr 20
Luciani, L. L., Miller, L. M., Zhai, B., Clarke, K., Hughes Kramer, K., Schratz, L. J., Balasubramani, G. K., Dauer, K., Nowalk, M. P., Zimmerman, R. K., Shoemaker, J. E., Alcorn, J. F. Blood Inflammatory Biomarkers Differentiate Inpatient and Outpatient Coronavirus Disease 2019 From Influenza. Open Forum Infectious Diseases. 2023; 10(3): ofa095.
- UPMC Award for Commitment and Excellence (ACES) Recipient, 2021
- Pittsburgh Business Times 30 Under 30 Award Recipient, 2022
